What is the patient’s role in informing the decision process for approval and reimbursement of new medicines?
7-th October 2015, Windsor, UK
This workshop built on CIRS workshops on this topic conducted during 2012-2014 and focused on the current processes and procedures as well as the similarities and differences in approaches and expectations between the three key stakeholders (industry, regulators and HTA) to elicit patient input and whether there can be a way of simply collecting patients’ views that can enable the patient’s perspective to inform company and agency decision making.
- Improve understanding of the importance and value of patient involvement
- Identify best practices in the acquisition of patient input into the decision-making process
- Recommend methods for leveraging the same patient input for industry, regulatory review and health technology assessment